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Abstract
There is no doubt that venous thromboembolism (VTE) is a complex and multicausal disease. Tuberculosis (TB) itself is found to 
have thrombogenic potential. There is an association between tuberculosis and VTE. We present a case of a 31-year-old male 
diagnosed with TB after a 2-month delay. He was treated with an anticoagulant for pulmonary embolism (PE) complicated by 
pulmonary infarction, and with antibiotics for presumed bacterial pneumonia. The patient did not improve despite in-hospital 
treatment. Finally, TB was diagnosed with positive sputum smear for acid fast bacilli and subsequent culture of Mycobacterium 
tuberculosis. Antituberculous therapy was uneventful and the patient was discharged home. Thrombophilia screening revealed 
a heterozygous factor V Leiden mutation. This case report emphasises that although there is a steady decline in active cases of 
TB, it should be still placed high on the list as a differential diagnosis in non-resolving lung infection or pulmonary infarction. This 
is especially relevant in cases with typical radiological findings located in the upper lobes. On the other hand, definitive diagnosis 
may be challenging in a case of concurrent TB, bacterial pneumonia and pulmonary infarction. Thromboembolic events may 
develop in TB patients without any clinical VTE risk factors. Therefore, thromboprophylaxis should be cautiously considered in 
this group of patients.
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Streszczenie
Żylna choroba zakrzepowo-zatorowa jest jednostką o złożonej i wieloczynnikowej etiologii. Gruźlica jako proces zapalny 
posiada potencjał prozakrzepowy. W literaturze opisywane jest współwystępowanie gruźlicy płuc i żylnej choroby zakrze-
powo-zatorowej. W pracy przedstawiono przypadek 31-letniego mężczyzny z zatorowością płucną powikłaną zawałem 
płuca oraz z rozpoznaną z dwumiesięcznym opóźnieniem gruźlicą płuc. U pacjenta zastosowano leki przeciwkrzepliwe oraz 
dodatkowo antybiotyki z powodu podejrzenia bakteryjnego zapalenia płuc. Stan kliniczny pacjenta nie poprawiał się pomimo 
hospitalizacji i zastosowanej terapii. Rozpoznanie zweryfikowano na podstawie dodatniego badania bezpośredniego plwociny, 
a następnie pozytywnej hodowli prątków gruźlicy (Mycobacterium tuberculosis). Leczenie przeciwprątkowe przebiegło bez 
powikłań. Badania w kierunku trombofilii potwierdziły heterozygotyczną mutację Leiden czynnika V. Mimo stałego spadku 
zachorowań, aktywna gruźlica powinna być nadal rozpoznaniem różnicowym w sytuacji niepoddających się leczeniu zmian 
zapalnych w płucach lub zawału płuca. Dotyczy to zwłaszcza przypadków ze zmianami radiologicznymi o typowej lokalizacji 
i charakterze. Z drugiej strony, ustalenie ostatecznego rozpoznania może sprawiać poważne trudności diagnostyczne przy 
współistnieniu gruźlicy, bakteryjnego zapalenia płuc oraz zawału płuca. Epizody zakrzepowo-zatorowych u pacjentów z gruź-
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licą mogą wystąpić bez klinicznych czynników ryzyka. W związku z tym profilaktykę przeciwzakrzepową należy wcześnie 
rozważyć w tej grupie chorych. 
Słowa kluczowe: gruźlica, zatorowość płucna, mutacja Leiden, diagnoza
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Case report
Despite a steady decline in TB incidence in 
Poland in recent years, this slightly underestima-
ted disease should be always taken into account 
in differential diagnosis in cases of non-resolving 
lung infection. In Poland TB incidence fell by 12% 
in 2012, compared with the previous year [1]. 
 There is some evidence that pulmonary tu-
berculosis is associated with VTE [2]. Besides the 
well-recognised fact that respiratory infections 
raise the risk of VTE, TB itself is linked with 
hypercoagulability [3, 4]. 
A 31-year-old lean (BMI 20 kg/m2) male 
smoker was admitted to a general medical ward 
with a history of two-week long productive 
purulent cough, intermittent haemoptysis, night 
sweats and weight loss of 10 kg. He was febrile 
(axillar temperature 380C), without dyspnea, 
fatigue or anorexia. One day before admission he 
reported a sharp central chest pain exacerbated 
by respiration. As an out-patient he received 
a course of amoxicillin for supposed commu-
nity-acquired pneumonia (CAP). He worked as 
a logistics manager with unremarkable medical 
history. There was no history of contact with 
TB source or any other socio-demographic risk 
factor for TB transmission except for smoking. 
He did not report any recent trauma, surgery or 
long-distance travel. On examination, he was 
normotensive (blood pressure — 110/70 mm Hg), 
non-tachycardic (85/min), non-tachypnic with 
bronchial breathing over the right upper lobe. 
His oxygen saturation was 93% in air. His legs 
were both non-tender and without oedema. His 
chest X-ray showed a large wedge-shaped con-
solidation in the upper right lobe abutting the 
horizontal fissure and parietal pleura with irre-
gular infiltrations in the middle and lower lobe 
of the right lung (Fig. 1). Doppler ultrasound exa-
mination of his legs was negative. Regarding his 
symptoms and chest X-ray, pulmonary infarction 
was suspected and computed tomographic pul-
monary angiography (CTPA) was ordered. It sho-
wed numerous emboli in a division of the right 
pulmonary artery, in all right upper lobe bran-
ches as well as the left lower lobe artery (Fig. 2). 
There were also infiltrations in peripheral parts 
of the right upper lobe with extensive air bron-
chogram and thickwalled cavity measuring 2 
cm in the second right segment (Figs 3, 4). The 
inflammatory markers were raised (erythrocyte 
sedimentation rate (ESR) — 58 mm/hour, C-re-
active protein (CRP) 119 mg/L). At that time the 
working diagnosis was large pulmonary infarc-
tion associated with CAP. Accordingly, he was 
treated with heparin and antibiotics (amoxicillin 
with clavulonic acid and ciprofloxacin). Given 
no evident risk factors and his young age, throm-
bophilia screening was performed. Among the 
investigated panel, including antiphospholipid 
antibodies and the prothrombin G20210A mu-
tation, heterozygous factor V Leiden mutation 
was the only positive finding. After moderate 
clinical improvement with a moderate decrease 
in CRP (36 mg/L), the patient was discharged to 
continue on oral anticoagulation. 
After a month the patient was readmitted 
with non-resolving fever, cough and sharp ri-
ght-side chest pain. Inflammatory markers were 
still elevated (CRP 65 mg/L, ESR 70). CT showed 
Figure 1. Chest X-ray on admission. Consolidation in the upper right 
lobe with irregular infiltrations in the middle and lower lobe of the 
right lung 
Rycna 1. Zdjęcie RTG klatki piersiowej przy przyjęciu. Naciek w gór-
nym płacie oraz nieregularne zmiany zapalne w środkowym i dolnym 
płacie płuca prawego
Pneumonologia i Alergologia Polska 2014, tom 82, nr 3, strony 264–270 
266 www.pneumonologia.viamedica.pl
Figure 2. Computed tomography (pulmonary angiography) with multipla-
nar reconstruction. Bilateral emboli mainly in the right pulmonary artery 
and its branches (arrows). Large consolidation in the right upper lobe
Rycina 2. Angio-KT tętnic płucnych. Rekonstrukcja wielopłaszczyzno-
wa. Obustronne skrzepliny głównie w prawej tętnicy i jej gałęziach 
(strzałki). Duże zagęszczenia w górnym prawym płacie
progressively larger consolidation in the upper 
right lobe and more cavities but with no emboli 
in arteries (Figs 5, 6). The patient was transferred 
to a respiratory ward in another hospital. Sputum 
microscopy was found to contain acid-fast bacilli 
(AFB+). Anti-tuberculous treatment (ATT) was 
Figure 3. Chest computed tomography (CT). Massive infiltrations in 
peripheral parts of the right upper lobe with prominent air broncho-
gram of all segmental bronchi 
Rycina 3. Tomografia komputerowa. Masywne zmiany zapalne 
w prawym płacie górnym z bronchogramem oskrzeli segmentowych
Figure 4. Chest CT. Thick-walled cavitary lesion in the second right 
segment 
Rycina 4. Tomografia komputerowa. Grubościenna jama w segmencie 
drugim płuca prawego
Figure 5. Chest CT. New cavitary lesions in the second right segment
Rycina 5. Tomografia komputerowa. Rozpady z utworzeniem nowych 
jam w drugim prawym segmencie
Figure 6. Chest CT. Cavities in the lower right lobe
Rycina 6. Tomografia komputerowa. Jamy w płacie dolnym prawym
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fallen (in 2012, 19.6 cases per 100,000 popula-
tion) [1]. Interestingly, we could hardly find any 
predisposing risk factors for TB as well as PE in 
the history. The only well-established risk factor 
for TB was smoking (RR = 2.3–2.7) [6]. Likewise, 
Sharif-Kashani et al. found that the majority (n 
= 28) of TB patients with coexisting VTE (n = 
46) did not have any evident VTE risk factor [7].
There is no doubt that VTE is a life-threate-
ning disease with a significant clinical burden. 
Although it is difficult to assess its frequency 
accurately due to its vague manifestations, the 
incidence of VTE among acute in-hospital pa-
tients in Europe varies from 3.65% to 14.9% [8]. 
Respiratory infections in general are reported to 
raise that risk [3].
Unfortunately, studies examining the co-
existence of TB and VTE are scarce in the litera-
ture. In a study from South Africa it was reported 
that up to 3.4% of adult patients with TB were 
diagnosed with deep vein thrombosis (DVT) [2]. 
Patients treated with rifampicin had more that 
4.5-times raised relative risk of DVT compared 
to those without it. Intriguingly, in the majority 
of these patients the diagnosis was made during 
the first 2 weeks of therapy and in winter months. 
While rifampicin is well known for its enzyme-in-
ducing effects, which complicate anticoagulant 
therapy, there is no clear explanation of that 
increased DVT risk.
In Italy, the prevalence of VTE in TB patients 
was much lower (0.6%) compared with that re-
ported by White et al. from South Africa in 1986 
[9]. That difference may be influenced by various 
epidemiologies of TB in these two countries as 
well as advances in VTE prevention. In addition, 
in the latter, DVT was not confirmed in some cases 
objectively and there were no data on comorbi-
dities. In a more recent retrospective study from 
Iran, the precise incidence of VTE was 1.3% [7]. 
What is interesting, the vast majority of these 
patients were admitted initially for TB therapy 
and later developed VTE. Again, these patients 
with in-hospital VTE did not have any risk factor 
for PE, except TB itself. 
Although VTE may be a presenting first ma-
nifestation of TB, it can be difficult to diagnose 
due to its non-specific symptoms. It was reported 
that only 10% of all VTE cases are thought to be 
apparent [10]. On the one hand, such a symp-
tom as haemoptysis is regarded as a complaint 
attributed to both PE and TB. In a large study of 
patients with confirmed PE, it was found only in 
the minority (9%) of patients [11]. Sudden onset 
dyspnea, chest pain and fainting were much 
started with rifampicin (R), isoniazid (H), etham-
butol (E) and pyrazinamide (Z) and piridoxine. 
Consequently, after 15 days, Mycobacterium tu-
berculosis was cultured with the MB/BacT system 
and later identified with MGIT (Mycobacteria 
Growth Indicator Tube). Drug susceptibility te-
sting (DST) showed sensitivity to first-line drugs, 
except for streptomycin. The patient improved 
with resolution of his general symptoms. There 
were no adverse affects. In order to avoid an 
interaction between rifampicin and warfarin he 
was anticoagulated with low-molecular-weight 
heparin. His sputum samples were negative for 
AFB after 2 months of ATT. Subsequently, after 
2 months of in-hospital treatment he was dischar-
ged with a good clinical response but very slow 
radiological one. After that he was treated as an 
out-patient with HR as a continuation phase for 
the next 4 months. In the 5th month there was a 
substantial resolution on the chest X-ray (Fig. 7). 
Discussion
 We report a case of pulmonary tuberculo-
sis diagnosed after a delay and complicated by 
thromboembolism. That delay in TB diagnosis 
may indicate that despite typical radiological fe-
atures, such as cavities and upper lobe location, 
TB might nowadays be slightly forgotten.
The absolute number of TB cases has been fal-
ling since 2006 and has dropped by 2.2% between 
2010 and 2011 [5]. The incidence worldwide is 
125/100,000 whereas in Poland it has recently 
Figure 7. Chest X-ray in the follow-up (the 5th month of ATT). Remar-
kable resolution of the consolidation in the right lung
Rycina 7. Zdjęcie kontrolne w 5. miesiącu leczenia przeciwprątkowe-
go. Znaczna regresja zmian w prawym płucu
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more frequently reported. On the other hand, 
systemic features such as fever, sweats and we-
ight loss with chronic cough are very suggestive 
of TB. Nonetheless, in a UK prospective study of 
confirmed pulmonary TB, up to 25% of patients 
did not report any of these [12]. Moreover, in 
a prevalence survey from South Africa, symptom 
screening was less sensitive for detection of TB 
than chest radiographic screening [13]. The for-
mer, including symptoms like cough longer than 
2 weeks, haemoptysis, night sweats, fever and 
weight loss, did not reveal any extra TB cases. 
Due to substantial delay in TB diagnosis, 
our patient was treated with several courses of 
antibiotics including quinolone and amoxicil-
lin/clavulanate. These drugs are found to have 
a degree of anti-mycobacterial activity. It has 
been suggested that it is quinolone treatment 
which may indeed cause a delay in diagnosis 
and therapy of TB [14]. That observation may 
be related to late TB diagnosis in the presented 
case. Likewise, in a European country with low 
TB burden, patients receiving various antibiotics 
experienced a significant delay in therapy [15]. 
However, that delay was not associated with any 
type of antibiotic or clinical improvement, but 
it was more due to prolongation of care. What is 
interesting, in 94% of cases the initial chest X-ray 
image was indicative of TB infection.
Gender and socio-cultural determinants of 
delay to TB diagnosis were also identified. In 
countries with high TB burden, such as India, 
Malawi and Bangladesh, female sex, status of 
married woman, housewife and non-specific 
symptoms like chest pain and breathlessness 
were associated with the longest delay of over 
90 days from initial symptoms to final diagnosis 
[16]. Cough in India, as a common TB symptom, 
was related to timely diagnosis. 
Diagnostic delay could also have been caused 
by radiological findings, which to some extent 
shared common qualities both with TB and pul-
monary embolism. In one-third of patients with 
PE but without infarction (90% of all patients) 
there is no evident imaging abnormality [17]. The 
remaining two-thirds were found to have some 
abnormal radiological features. The most frequent 
non-specific findings were plate-like atelectasis, 
areas of consolidation, a pleural effusion and 
vascular changes (focal oligaemia, local widening 
of a vessel). Whereas in half of patients with in-
farction, chest X-ray shows consolidation, which 
classically is a truncated cone with a pleural base 
(Hampton’s hump). The most frequent radiologi-
cal findings in acute PE were cardiac enlargement 
(27%), normal chest X-ray (24%) and pleural 
effusion (23%) [18]. In the radiographic scoring 
system for TB, the most frequent features were 
upper-lobe opacity (adjusted odds ratio [aOR] 
4.2; 95% CI 2.1, 8.3), cavity of any location (aOR 
4.0; 95% CI 2.0, 7.6), adenopathy of any location 
(aOR 3.8; 95% CI 1.7, 8.2) and unilateral pleural 
effusion (aOR 2.1; 95% CI 1.5, 4.2) [19]. Besides, 
it was reported that patients with recurrent PE 
requiring inferior vena cava ligation may develop 
lung abscess [20]. This phenomenon was also 
confirmed in at least 2 case-reports describing 
relatively high incidence of aseptic cavitations of 
a sterile pulmonary infarction [21, 22]. Although 
lung abscess following PE seems rather unusual, 
this possible aetiology of a cavitary lesion other 
than TB may be considered in a patient with 
pulmonary infarction. 
In the presented case it is very challenging 
to elucidate the main cause of the radiological 
findings. The initial CT scans presented large 
consolidation in the right lung and extensive 
filling defects in branches of the right pulmonary 
artery. These findings suggested the diagnosis 
of lung infarction. However, from the perspec-
tive of completed treatment and  its outcomes 
it appears that  it is TB rather than pulmonary 
embolism and  infarction that  contributed to 
the radiological presentation. This is supported 
by the remarkable improvement on ATT in the 
5th month. In contrast, there was gradual clinical 
and imaging progression after only two months 
of anticoagulation and antibiotics with no anti
-tuberculous therapy. Moreover, on the second 
hospital admission, the consolidation was even 
larger with more numerous cavities, in spite of 
complete resolution of extensive embolism in 
pulmonary arteries.
TB might be also associated with atypical 
location of thrombosis, such as cerebral venous 
thrombosis in a heterozygous patient for pro-
thrombin mutation [23]. There may be also a link 
between extrapulmonary TB, such as gastrointe-
stinal, and DVT [24]. These observations may con-
firm the thrombogenic potential of tuberculosis. 
Undoubtedly, there is firm evidence for the 
hypercoagulable state in tuberculosis. Robson et 
al. found that plasma fibrinogen was increased in 
patients with active TB coupled with lower level 
of antithrombin III and reactive thrombocytosis 
[4]. These haemostatic changes improved on 
ATT. Lang et al. found that plasminogen activa-
tor inhibitor and tissue factor antigen were also 
increased in pulmonary endothelial cells from a 
patient with pulmonary embolism and TB [25]. 
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One possible explanation is significant secretion 
of cytokines like tumour necrosis factor alpha 
(TNF-a) and interleukin-6 (IL-6) by monocytes/ 
/macrophages in TB patients [26]. As a result, 
they can induce hepatic acute-phase response and 
a subsequent change in coagulation proteins such 
as fibrinogen. Finally, the release of these cytoki-
nes from peripheral mononuclear cells (PBMC) 
can be further enhanced by the killing effect of 
isoniazid and rifampicin.
Our patient was positive for the heterozygous 
factor V Leiden (FVL) mutation. This most com-
mon inherited cause of thrombophilia is present 
in approximately 15–20% of patients with veno-
us thromboembolism, and its prevalence in the 
general white population varies between 2% and 
15% [27]. While, in heterozygous carriers of FVL, 
VTE risk is increased moderately (3- to 5-fold), it 
is estimated that homozygous patients have that 
risk elevated up to 80 times [28]. Despite this 
high risk, FVL is recognised as a rather modest 
thrombophilic defect which still does not cause 
VTE in all carriers. The thrombotic risk depends 
very much on the interaction with other muta-
tions or, more frequently, with acquired high-risk 
situations [28]. Moreover, there is ongoing debate 
about its routine testing, which is recommended 
only on an individual basis [29]. However, there 
is no doubt that this risk of thrombosis is eleva-
ted during an inflammatory state. In fact, it has 
been suggested that the inflammatory response 
may further increase  the thrombotic risk in FVL 
patients. Damage of the  endothelium as well as 
exposure of adhesion molecules may play a major 
role in upregulating the thrombophilic state in 
this group of patients [30]. Last but not least, the 
risk of PE is only mildly elavated in FVL carriers. 
On the contrary, the risk with FVL for DVT is 
much higher (OR 4.5 95% CI 3.8 to 5.3) vs.  PE 
(OR 1.7  95% CI 1.3  to 2.2) [31]. So far there has 
not been found a clear explanation for this so-cal-
led Factor V Leiden paradox. There has not been 
found a clear explanation for the FVL paradox. 
In conclusion, a differential or coexisting 
diagnosis of pulmonary tuberculosis in a case of 
non-responsive chest infection as well as large 
pulmonary infarction should be always con-
sidered. Consequently, TB can be the possible 
diagnosis of presumed bacterial pneumonia. In 
such cases, appropriate TB-focused investigations 
such as sputum smear and culture should be 
performed. On the other hand, a hypercoagulable 
state secondary to acute inflammation is reported 
in these patients [32]. Consequently, patients, 
especially those with no improvement on ATT or 
with predisposing factors, should be thoroughly 
monitored for VTE. Patients with TB may develop 
VTE even without other predisposing conditions. 
Therefore, prevention should be cautiously con-
sidered regardless of any risk factors. 
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